< Back to latest news & events

Brexit

Brexit Delay Agreed – Update on EU and UK Trade Mark Protection

April 2019

The EU has agreed to grant the UK a further extension of time (until 31 October 2019) to finalise the terms of how the UK leaves the EU. This removes the “cliff edge” of the UK potentially leaving the EU without a deal on 12 April 2019.

The extension will allow the UK Parliament more time to ratify a withdrawal agreement. During this extended period, the UK will continue to fully participate in the EU IPO system and to be covered by EU trade mark and design registration and protection.

Provided a withdrawal agreement is in place on 31 October 2019, there will then be a further transitional period until at least January 2021 – potentially longer – where nothing changes and the UK continues to be part of the EU trade mark and design registration systems.

After that transitional period:

  1. new UK trade mark and design registrations will be automatically created which mirror their EU counterpart registrations;
  2. for any pending EU trade mark and Community design applications, owners will have 9 months to file a UK application which mirrors their EU application and will benefit from the same filing and priority dates.

Despite the UK’s political position still being unclear, the implications for EU trade mark and design protection post Brexit is well established. That is, after this further extension and a lengthy transitional period, EU rights will be maintained and replicated in the UK when the UK eventually leaves the EU.

What’s next?

HGF’s message to clients continues to be one of “business as usual”, with the UK continuing to be part of the EU IPO for further considerable time.

HGF will ensure that your trade mark and design rights are maintained and protected throughout the EU and the UK by taking all necessary actions on your behalf when it is necessary to do so.

With offices in 6 European countries, HGF is ideally placed to handle all EU and UK trade mark, design and other intellectual property matters. We will continue to be your trusted advisers and representatives of both the EU IPO and the UK IPO.

If you have any queries at all, please contact your usual HGF attorney, or David Potter, Head of the HGF Trade Mark Team.

Latest updates

UK IPO fees to increase from 1 April 2026

Whilst the fee changes are subject to parliamentary approval, they are almost certain to take effect – read on to learn more. The United Kingdom Intellectual Property Office (UK IPO) …

Read article

Mycelium Meets Market Reality: The Quiet Role of IP in Scaling Sustainable Materials

Fungal materials are increasingly used in applications ranging from sustainable packaging and leather alternatives to construction composites, textiles, and biotechnology. These developments are transforming fungi from a niche research subject …

Read article
Event - 24th - 25th November 2025

HGF Partners with 3AF for the P2I2025 Symposium

HGF are pleased to be a partner of P2I2025, the annual symposium organised by the Intellectual Property Commission of the French Aeronautics and Astronautics Association (3AF). The event brings together …

Event details

Retailers liability and AI Applications

The question of whether the user (consumer) or the provider of an AI application is liable for the infringement of intellectual property rights as a result of the use of …

Read article
Event - 11th November 2025

OIS Investor Forum - Jeffries

HGF is proud to be sponsoring the OIS Investor Forum on 18th November. One of the premier gatherings for leaders, innovators, and investors across the healthcare industry. The forum covers …

Event details

From Stripes to Supermarkets: The Court of Appeal Reaffirms the Need for Precision in Trade Mark Law

On 23 October 2025, Lord Justice Arnold delivered two landmark Court of Appeal decisions addressing trade mark registrability: Thom Browne Inc & Anor v adidas AG [2025] EWCA Civ 1340 …

Read article

Protecting Digital Health innovation in the AI revolution

As artificial intelligence (AI) continues to transform healthcare, from diagnostic imaging and drug discovery to wearable devices and clinical decision support, questions around how to protect these advancements have become …

Read article

Doubling Up on Added Matter at the UPC

Following the UPC Court of Appeal (CoA) decision in Abbott v Sibio (APL_39664/2024, 14 February 2025) we now have a second CoA decision on added matter in expert Klein v …

Read article